Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001648841-15-000001
Filing Date
2015-07-27
Accepted
2015-07-27 13:32:04
Documents
1
Effectiveness Date
2015-07-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7160
  Complete submission text file 0001648841-15-000001.txt   8160
Mailing Address 4240 DUNCAN AVE. ST. LOUIS MO 6310
Business Address 4240 DUNCAN AVE. ST. LOUIS MO 6310 925-899-2669
Epharmix, Inc. (Filer) CIK: 0001648841 (see all company filings)

EIN.: 473940610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-244490 | Film No.: 151006671